NCT04525183View on ClinicalTrials.gov

REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

December 2, 2020

Primary Completion Date

August 9, 2022

Study Completion Date

August 9, 2022

Conditions
Ovarian CancerFatigueCoping BehaviorCoping Skills
Interventions
BEHAVIORAL

Enhanced Usual Care (EOC)

Educational materials

BEHAVIORAL

REVITALIZE ACT Intervention

Six 60-75 minute telehealth sessions approximately once a week for 6-8 weeks

Trial Locations (2)

19104

University of Pennsylvania, Philadelphia

02215

Dana Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

National Comprehensive Cancer Network

NETWORK

lead

Dana-Farber Cancer Institute

OTHER